Intensive Services Grand Rounds

Psilocybin and MDMA: Updates on Research

Brian T. Anderson, MD, MSc
Postdoctoral Research Fellow
San Francisco VA Medical Center
UCSF Weill Institute for Neurosciences

Christopher Stauffer, PhD
Assistant Adjunct Professor of Psychiatry
UCSF Weill Institute for Neurosciences


Learning objectives:

  • Attendees will be able to make an informed assessment of the psychotherapeutic benefits and risks of psilocybin- and MDMA-assisted psychotherapy.

  • Attendees will be able to compare and contrast psilocybin- and MDMA-assisted psychotherapy with current models of mental health treatment involving psychiatric medications +/- psychotherapy. 

  • Attendees will be able to evaluate indications and contraindications for the use of psilocybin- and MDMA-assisted psychotherapy as an adjunct to ongoing mental health treatment, and determine when it may be appropriate to refer patients with difficult-to-treat psychiatric disorders.


Intensive Services Grand Rounds presentations are for educational purposes and are intended only for an audience of medical professionals.

Continuing Medical Education (CME) credits will be available for licensed physicians participating in this activity. You must attend this event in-person and sign in to qualify for CME credit.

Monday, October 22, 2018 at 1:00pm to 2:00pm

LP-190 Auditorium
401 Parnassus Ave., San Francisco, CA 94143